D-0017-2027 Class II Ongoing

Recalled by Carolina Infusion, LLC — Ridgeland, SC

FDA drug recall D-0017-2027 was initiated by Carolina Infusion, LLC on Sep 10, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. The recall status is ongoing. Affected quantity: 5.6 mLs - in patient specific syringe doses.

Recall details

Product Type
Drugs
Report Date
Oct 14, 2026
Initiation Date
Sep 10, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5.6 mLs - in patient specific syringe doses

Product description

TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;

Reason for recall

Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Distribution pattern

Nationwide within the U.S

Code information

Lots: 09012026@3, BUD: 10/16/2026; 08032026@16, BUD: 9/17/2026; 08052026@8, BUD: 9/19/2026; 08072026@13, BUD: 9/21/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0017-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0017-2027. Report a data issue: hello@regdatalab.com.